Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin versus clobazam for prevention of recurrent febrile seizures
IRCT20221102056380N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in febrile seizure (FS) comparing Melatonin arm with Clobazam arm (2 arms). Primary endpoints: Recurrence of subsequent simple febrile seizures and Drug side effects. Started Oct 2020; status: completed.
02
Drugs
melatoninclobazam
03
Conditions
febrile seizure (FS)
Beyond the preview
Go deeper on IRCT20221102056380N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221102056380N1.